Endurant Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,240	Closed	-$469K	–	81
2015 Q2	$469K	Sell	1,240 -2,493	-67%	-$943K	0.14%	87
2015 Q1	$1.56M	Buy	+3,733	New	+$1.56M	0.52%	59